Skip to content

Study of the Efficacy and Safety of Kalinox® 170 Bar for the Performance of Care Procedures in Children With Burns

Study of the Efficacy and Safety of KALINOX® 170 Bar for the Performance of Care Procedures in Children With Burns

Status
Withdrawn
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00643357
Acronym
Burns
Enrollment
0
Registered
2008-03-26
Start date
2008-03-31
Completion date
2009-01-31
Last updated
2012-01-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Burns

Keywords

children with burns, Child between 5 and 15 years of age , burned for many days and who has to undergo at least 3 procedures of care

Brief summary

The purpose of this study is to assess the efficacy and the safety of Kalinox® 170 bar, over a period of three consecutive care procedures in burned children. It's a international (Spain, France, Tunisia and Belgium) study with 8 investigator centers.

Detailed description

Pain due to burns is one of the most intense and persistent types of pain. This pain consists of a permanent background pain, overlaid by episodes of temporary exacerbations triggered by treatment procedures or burn-care procedures. Care procedures, such as changing the dressings or cleaning the wounds, make it necessary to handle the painful areas, and this causes transient intense pain. Analgesia with a 50/50 mix of nitrous oxide and oxygen is a simple and effective technique, which induces a state of light sedation during which verbal contact is not lost, which is rapidly reversible and is devoid of any major side effects. This gas is used in paediatrics for carrying out painful procedures of a short duration, such as lumbar puncture and minor surgery. The nitrous oxide/oxygen mix has also been used to treat the pain induced by care procedures in children with burns for more than 30 years. The objective of our study is to obtain qualitative and quantitative data about the efficacy of Kalinox® 170 bar in care procedures in children with burns.

Interventions

gaz flow between 4 to 15 L/min inhalation between 15 to 60 minutes

DRUG50%Oxygen/50% Nitrogen premix

inhalation between 15 to 60 minutes gaz flow between 4 to 15 l/min

Sponsors

Air Liquide Santé International
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
4 Years to 15 Years
Healthy volunteers
No

Inclusion criteria

* Child between 5 and 15 years of age , burned for many days and who has to undergo at least 3 procedures of care * potentially mildly to moderately painful * lasting for at least 15 minutes and for less than 30 minutes * eligible to receive short-term prophylactic analgesic treatment * for whom the consent form has been signed (parent and child)

Exclusion criteria

* Child treated under general anaesthesia * Child physically or mentally incapable of responding to an assessment of his/her pain on a visual scale. * Child suffering from moderate to severe pain when beginning the care procedure (FPSr \> 4) *

Design outcomes

Primary

MeasureTime frame
The intensity of the pain was assessed using the Faces Pain Scale RevisedFaces Pain Scale Revised

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026